Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01115673 · ClinicalTrials.gov registry record · Phase 3

To Evaluate the Safety and Efficacy of Acetaminophen 650 mg and 1000mg in Dental Pain After Surgery

A Phase 3 study of Pain, sponsored by McNeil Consumer Healthcare Division of McNEIL-PPC.

Completed
Registry status
Phase 3
Development phase
540
Enrollment target
1
Study location

NCT01115673: Completed Phase 3 study of Pain, sponsored by McNeil Consumer Healthcare Division of McNEIL-PPC.

NCT01115673 is a Phase 3 study of Pain that has completed, run by McNeil Consumer Healthcare Division of McNEIL-PPC. The registered enrollment target is 540 participants, above the 303-participant average among 374 other Pain trials with a reported enrollment target (78% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT01115673, a Phase 3 study of Pain, has completed, sponsored by McNeil Consumer Healthcare Division of McNEIL-PPC.

COMPLETED
Registry status
Phase 3
Development phase
540 participants
Enrollment target
1
Study location

Study Summary

The objective of this study is to evaluate the safety and efficacy of acetaminophen 650 mg and acetaminophen 1000 mg in dental surgery.

Primary Outcome

Weighted Sum of Pain Intensity Difference and Pain Relief Scores Over Six Hours (SPRID6) - pain intensity and pain relief were evaluated using a 0-100 mm visual analog scale (VAS) where 0 = no pain and 100 = very severe pain for pain intensity and 0 = no relief and 100 = complete relief for pain relief. For SPRID6, the total possible minimum value is -300 (worst) and the total possible maximum value is 1200 (best). The weights used in the calculation of weighted sums were equal to the elapsed ti

Conditions Studied

Interventions

  • DRUG Acetaminophen
  • DRUG Placebo Control

Study Locations (1)

Utah

  • Jean Brown Research - Salt Lake City

Trial Details

FieldValue
Enrollment Target 540 participants
Start Date 2010-06
Est. Completion 2011-01
Phase Phase 3

What the finished NCT01115673 record still lists

NCT01115673 is an interventional study that assigns participants to a tested intervention. The registered 540 participants enrollment target is mid-sized for trials with a published cap, above the 303-participant average among 374 other Pain trials with a reported enrollment target (78% higher).

The record links to 1 condition, with Pain appearing as the primary indexed condition, and to 2 interventions - of which Acetaminophen is the first listed.

NCT01115673 reports a single indexed study location in Utah.

Frequently Asked Questions

What is clinical trial NCT01115673 about?

NCT01115673 is a clinical study titled "To Evaluate the Safety and Efficacy of Acetaminophen 650 mg and 1000mg in Dental Pain After Surgery". The objective of this study is to evaluate the safety and efficacy of acetaminophen 650 mg and acetaminophen 1000 mg in dental surgery.

What is the current status of trial NCT01115673?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 540 participants. The study started on 2010-06. Estimated completion is 2011-01.

What conditions does trial NCT01115673 study?

This clinical trial studies the following conditions: Pain.

What interventions are being tested in trial NCT01115673?

The interventions under investigation include: Acetaminophen (DRUG), Placebo Control (DRUG).

Who is sponsoring clinical trial NCT01115673?

This trial is sponsored by McNeil Consumer Healthcare Division of McNEIL-PPC, which has 6 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01115673 being conducted?

This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01115673's enrollment target sits among peer trials

540 27th of 374 higher than 348 of 374 other Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04557462 · 540 participants · Phase 3

    A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy

  • NCT04956640 · 540 participants · Phase 1

    Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)

  • NCT05429892 · 540 participants · NA

    FRESH Delivers: An Innovative Approach to Reducing Tobacco Use Among Rural Smokers

  • NCT05549297 · 540 participants · Phase 3

    Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01115673, the US trial registry maintained by the National Library of Medicine. NCT01115673 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.